RFK Jr. peptides, Sanofi insulin, CRISPR-related death: Readout

RFK Jr. peptides, Sanofi insulin, CRISPR-related death: Readout
RFK Jr. peptides, Sanofi insulin, CRISPR-related death: Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, a win for RFK Jr., as an FDA panel narrowly voted in favor of allowing compounding pharmacies to produce certain unregulated peptides. Also, in heart-wrenching detail, Science writes of the six-year-old girl who died in China after receiving an experimental, brain-directed CRISPR therapy.

The Readout’s taking a summer break next week, so we’ll see you in August!

STAT+ Exclusive Story

STAT+





This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Leave a Reply

Your email address will not be published. Required fields are marked *